Manufactures and develops heparin and polysaccharide-based pharmaceuticals — heparin sodium, enoxaparin, dalteparin, nadroparin — and expanding pipeline with sulodexide, ferric carboxymaltose and mucopolysaccharide polysulfate cream. Operates crude heparin production with strict traceability and quality systems, backed by R&D labs, a post‑doctoral research center, patents and participation in national drug-development programs.